Your browser doesn't support javascript.
loading
The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment.
Robbins, Mike E; Payne, Valerie; Tommasi, Ellen; Diz, Debra I; Hsu, Fang-Chi; Brown, William R; Wheeler, Kenneth T; Olson, John; Zhao, Weiling.
Affiliation
  • Robbins ME; Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Int J Radiat Oncol Biol Phys ; 73(2): 499-505, 2009 Feb 01.
Article in En | MEDLINE | ID: mdl-19084353
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Radiation Injuries, Experimental / Tetrazoles / Cranial Irradiation / Cognition Disorders / Angiotensin II Type 1 Receptor Blockers / Imidazoles Type of study: Etiology_studies Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2009 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Radiation Injuries, Experimental / Tetrazoles / Cranial Irradiation / Cognition Disorders / Angiotensin II Type 1 Receptor Blockers / Imidazoles Type of study: Etiology_studies Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2009 Type: Article Affiliation country: United States